Virtual Medicinal Product (VMP) - Amphotericin B (lipid formulation) 50mg powder for solution for infusion vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Amphotericin B (lipid formulation) 50mg powder for solution for infusion vials Start Date 13-01-2009 End Date
Previous Name Previous Name Amphotericin B (lipid formulation) 50mg powder for solution for injection vials Start Date 11-10-2007 End Date 12-01-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Invalid
Prescribing Status
Caution - AMP level prescribing advised
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Powder for solution for infusion
Ontology Form/Route
solutioninfusion.intravenous
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
J02AA01
BNF Start Date End Date
Previous BNF 05020300 Start Date 05-11-2010 End Date 03-04-2022
Previous BNF 05020000 Start Date 31-10-2005 End Date 04-11-2010
SNOMED Codes
Code Start Date End Date
9730811000001105 31-10-2005

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Amphotericin B Based on Ingredient Substance 50 mg

Parent Products

  • VTM
    No Parent VTM
    • VMP
      (Current) Amphotericin B (lipid formulation) 5...
      • AMP
        No AMP's

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial
10 vial